Skye Bioscience, Inc. - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2018-03-29

Reporting Person: Emerald Health Sciences Inc. (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-29	Common Stock	C	12335000	$0.10	Acquired	53116250	Direct
2018-03-29	Common Stock	C	20000000	$0.10	Acquired	73116250	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-29	Series B Convertible Preferred Stock	$0.10	C	1233.5	Disposed		Common Stock (12335000)	Direct
2018-03-29	Series F Convertible Preferred Stock	$0.10	C	2000	Disposed		Common Stock (20000000)	Direct

F1: The Series B Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date.

F2: The Series F Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date.